Cadila Healthcare is currently trading at Rs. 875.00, up by 21.20 points or 2.60% from its previous closing of Rs. 853.20 on the BSE.
The scrip opened at Rs. 861.80 and has touched a high and low of Rs. 883.80 and Rs. 855.00 respectively. So far 34,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 924.60 on 22-Feb-2013 and a 52 week low of Rs. 631.00 on 20-Aug-2013.
Last one week high and low of the scrip stood at Rs. 883.80 and Rs. 815.00 respectively. The current market cap of the company is Rs. 17,915 crore.
The promoters holding in the company stood at 74.79% while Institutions and Non-Institutions held 13.80% and 11.41% respectively.
The company has reported around four fold jump in its net profit at Rs 194.93 crore for the quarter as compared to Rs 48.65 crore for the same quarter in the previous year. Total income of the company has increased by 24.67% at Rs 1087.48 crore for quarter under review as compared to Rs 872.28 crore for the quarter ended December 31, 2012.
On the consolidated basis, the group has reported 81.54% rise in its net profit after taxes and Minority Interest at Rs 185.97 crore for the quarter as compared to Rs 102.44 crore for the same quarter in the previous year. Total income of the group has increased by 16.58% at Rs 1884.47 crore for quarter under review as compared to Rs 1616.42 crore for the quarter ended December 31, 2012.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: